Functional Expression, Characterization, and Purification of the Catalytic Domain of Human 11-β-Hydroxysteroid Dehydrogenase Type 1
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
11-beta-hydroxysteroid dehydrogenase type 1 catalyzes the conversion of cortisone to hormonally active cortisol and has been implicated in the pathogenesis of a number of disorders including insulin resistance and obesity. The enzyme is a glycosylated membrane-bound protein that has proved difficult to purify in an active state. Extracted enzyme typically loses the reductase properties seen in intact cells and shows principally dehydrogenase activity. The C-terminal catalytic domain is known to contain a disulfide bond and is located within the lumen of the endoplasmic reticulum, anchored to the membrane by a single N-terminal transmembrane domain. We report here the functional expression of the catalytic domain of the human enzyme, without the transmembrane domain and the extreme N terminus, in Escherichia coli. Moderate levels of soluble active protein were obtained using an N-terminal fusion with thioredoxin and a 6xHis tag. In contrast, the inclusion of a 6xHis tag at the C terminus adversely affected protein solubility and activity. However, the highest levels of active protein were obtained using a construct expressing the untagged catalytic domain. Nonreducing electrophoresis revealed the presence of both monomeric and dimeric disulfide bonded forms; however, mutation of a nonconserved cysteine residue resulted in a recombinant protein with no intermolecular disulfide bonds but full enzymatic activity. Using the optimal combination of plasmid construct and E. coli host strain, the recombinant protein was purified to apparent homogeneity by single step affinity chromatography. The purified protein possessed both dehydrogenase and reductase activities with a K(m) of 1.4 micrometer for cortisol and 9.5 micrometer for cortisone. This study indicates that glycosylation, the N-terminal region including the transmembrane helix, and intermolecular disulfide bonds are not essential for enzyme activity and that expression in bacteria can provide active recombinant protein for future structural and functional studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, the net flux of steroid driven by 11HSD1 depends on the relative concentrations of available NADPH and NADP ϩ , which usually favors reduction in cells, especially given the high K m of the enzyme for cortisol (577).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [577]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Holmgren, A. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.001321 · Cited by 1,951
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249
LaVallie, E. R., DiBlasio, E. A., Kovacic, S., Grant, K. L., Schendel, P. F., & McCoy, J. M. (1993) · Nature Biotechnology · doi:10.1038/nbt0293-187 · Cited by 919
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Self-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationTannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Stewart, E. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5543 · Cited by 432
Walker, B. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3155 · Cited by 277
Research works printed but not linked: 8
- Obeid, 1993, Mol. Endocrinol., 7, 154
- Stewart, 1994, J. Clin. Endocrinol. Metab., 79, 480
- Ricketts, 1998, J. Clin. Endocrinol. Metab., 83, 1325
- LaVallie, 1993, Bio/Technology, 11, 187
- Walker, 1995, J. Clin. Endocrinol. Metab., 80, 3155
- Phillipov, 1996, J. Clin. Endocrinol. Metab., 81, 3855
- Tanabe, 1998, Biochemistry, 124, 634
- Morris, 1996, Exp. Hematol., 24, 1369
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“03 indicates a strong preference toward dehydrogenase (F to E) activity (82).”
Self-citation11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
“In support of this finding, recent data conclusively show fully active non-glycosylated 11 -HSD1 enzyme activity generated in E. coli, with kinetic properties for both dehydrogenase and reductase activities similar to those reported in mammalian systems (Walker et al. 2001).”
BackgroundInfluentialSelf-citationArlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Self-citationDraper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
“whereas purified enzyme acts as a dehydrogenase converting cortisol to cortison”
BackgroundSelf-citationLavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512635200 · Cited by 207
Self-citationBujalska, I. J., Draper, N., Michailidou, Z., Tomlinson, J. W., White, P. C., Chapman, K. E., Walker, E. A., & Stewart, P. M. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01718 · Cited by 165
“…as a dehydrogenase (Lakshmi & Monder 1988); oxo-reductase activity can only be recovered in these situations upon the addition of an artificial NADPH re-generation system, such as can be provided by the activity of glucose-6-phosphate dehydrogenase (G6PD) (Agarwal et al. 1990, Walker et al. 2001).”
BackgroundSelf-citationHewitt, K. N., Walker, E. A., & Stewart, P. M. (2005) · Endocrinology · doi:10.1210/en.2005-0117 · Cited by 149
“can be restored in vitro by the addition of G6PDH and NADP to regenerate NADPH (27, 32).”
BackgroundSelf-citationZhang, L., Chou, C.-H. P., & Moo‐Young, M. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.013 · Cited by 148
Wang, J., Sun, B., Hou, M., Pan, X., & Li, X. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.173 · Cited by 146
Agarwal, A. K., & Auchus, R. J. (2005) · Endocrinology · doi:10.1210/en.2005-0061 · Cited by 112
“Paradoxically, recombinant 11 -HSD1, overexpressed in cultured cells infected with vaccinia virus (40) or in Escherichia coli (41), reduces cortisone poorly in vitro with NADPH.”
BackgroundHosfield, D. J., Wu, Y., Skene, R. J., Hilgers, M., Jennings, A., Snell, G. P., & Aertgeerts, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411104200 · Cited by 102
A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
Bujalska, I. J., Gathercole, L. L., Tomlinson, J. W., Darimont, C., Ermolieff, J., Fanjul, A. N., Rejto, P. A., & Stewart, P. M. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0050 · Cited by 84
“…oxo-reductase activity with a Km for cortisone in Chubb-S7 cells of 100 nM which is similar to the reports in other 11b-HSD1-expressing cell systems (Monder & Lakshmi 1989, Ricketts et al. 1998) including studies on the recombinant enzyme (KmZ333 nM;Walker et al. 2001, Shafqat et al. 2003).”
MethodSelf-citationDifferential Inhibition of CYP17A1 and CYP21A2 Activities by the P450 Oxidoreductase Mutant A287P
Dhir, V., Ivison, H. E., Krone, N., Shackleton, C. H. L., Doherty, A. J., Stewart, P. M., & Arlt, W. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0066 · Cited by 78
Self-citation11β-Hydroxysteroid dehydrogenase: unexpected connections
Walker, E. A., & Stewart, P. M. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00134-6 · Cited by 72
Self-citation11β-hydroxysteroid dehydrogenases: A growing multi-tasking family
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111210 · Cited by 89
“than reductase activity in artificial systems (Walker et al., 2001).”
BackgroundEnvironmental Pollutants and Hydroxysteroid Dehydrogenases
Ye, L., Guo, J., & Ge, R. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800095-3.00013-4 · Cited by 73
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases
Beseda, I., Czollner, L., Shah, P., Khunt, R. C., Gaware, R., Kosma, P., Stanetty, C., Ruiz-Ruiz, M. C. D., Amer, H., Mereiter, K., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.036 · Cited by 73
Lawson, A. J., Walker, E. A., Lavery, G. G., Bujalska, I. J., Hughes, B., Arlt, W., Stewart, P. M., & Ride, J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014934108 · Cited by 61
“We addressed this question using our previously developed bacterial expression system (22, 23), together with a mammalian cell expression system.”
MethodSelf-citationWalker, E. A., Ahmed, A., Lavery, G. G., Tomlinson, J. W., Kim, S. Y., Cooper, M. S., Ride, J. P., Hughes, B. A., Shackleton, C. H. L., McKiernan, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704144200 · Cited by 59
Self-citationSDR-type human hydroxysteroid dehydrogenases involved in steroid hormone activation
Wu, X., Lukacik, P., Kavanagh, K. L., & Oppermann, U. C. T. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.006 · Cited by 61
Goggin, S. L., Labrecque, M. T., & Allan, A. M. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.08.010 · Cited by 53
“In our study, we found a decrease in the levels of the glycosylated form of the enzyme, which some maintain is the active form of the enzyme, although other studies have shown that the 11βHSD1 does not need to be fully glycosylated to be enzymatically active (Blum et al., 2000; Walker et al., 2001).”
ResultSemjonous, N. M., Sherlock, M., Jeyasuria, P., Parker, K. L., Walker, E. A., Stewart, P. M., & Lavery, G. G. (2011) · Endocrinology · doi:10.1210/en.2010-0957 · Cited by 51
“Medium was then removed, steroids extracted, and enzyme activities analyzed as previously described (23).”
MethodSelf-citationRogoff, D., Ryder, J. W., Black, K., Yan, Z., Burgess, S. C., McMillan, D. R., & White, P. C. (2007) · Endocrinology · doi:10.1210/en.2007-0593 · Cited by 55
Frick, C., Atanasov, A. G., Arnold, P., Ozols, J., & Odermatt, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313666200 · Cited by 55
Thieringer, R., & Hermanowski‐Vosatka, A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.911 · Cited by 48
Odermatt, A., & Nashev, L. G. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.007 · Cited by 51
Enzymology and Molecular Biology of Glucocorticoid Metabolism in Humans
Blum, A., & Maser, E. (2003) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(03)75006-5 · Cited by 50
Goldberg, F. W., Leach, A. G., Scott, J. S., Snelson, W. L., Groombridge, S. D., Donald, C. S., Bennett, S. N. L., Bodin, C., Gutierrez, P. M., & Gyte, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3013163 · Cited by 39
Zhu, L., Hou, M., Sun, B., Burén, J., Zhang, L., Yi, J., Hernell, O., & Li, X. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2708 · Cited by 32
Favia, A. D., Masetti, M., Recanatini, M., & Cavalli, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025375 · Cited by 29
“Taking into account in vitro assays, it has been suggested that 11b-HSD-1 minimally functional unit is a dimer [7,29,30].”
BackgroundStructural Role of Conserved Asn179 in the Short-Chain Dehydrogenase/Reductase Scaffold
Filling, C., Nordling, E., Benach, J., Berndt, K. D., Ladenstein, R., Jörnvall, H., & Oppermann, U. C. T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6032 · Cited by 36
Differential Modulation of 3T3-L1 Adipogenesis Mediated by 11β-Hydroxysteroid Dehydrogenase-1 Levels
Kim, J., Temple, K. A., Jones, S. A., Meredith, K. N., Basko, J. L., & Brady, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606197200 · Cited by 29
Shafqat, N., Elleby, B., Svensson, S., Shafqat, J., Jörnvall, H., Abrahmsén, L., & Oppermann, U. C. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210135200 · Cited by 29
Bezsudnova, E. Y., Boyko, K. M., Polyakov, K. M., Дороватовский, П. В., Stekhanova, T. N., Gumerov, V. M., Ravin, N. V., Skryabin, K. G., Kovalchuk, M. V., & Popov, V. O. (2012) · Biochimie · doi:10.1016/j.biochi.2012.07.024 · Cited by 25
Park, J., Kagaya, N., Hashimoto, J., Izumikawa, M., Yabe, S., Shin‐ya, K., Nishiyama, M., & Kuzuyama, T. (2014) · ChemBioChem · doi:10.1002/cbic.201300690 · Cited by 27
Thurston, L. M., Abayasekara, D. R. E., & Michael, A. E. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07025 · Cited by 29
“Journal of Endocrinology (2007) 193, 299–310 individual protein molecules (Walker et al. 2001).”
BackgroundInhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 in Antidiabetic Therapy
Wang, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_6 · Cited by 29
17β-Estradiol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes
Tagawa, N., Yuda, R., Kubota, S., Wakabayashi, M., Yamaguchi, Y., Kiyonaga, D., Mori, N., Minamitani, E., Masuzaki, H., & Kobayashi, Y. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0021 · Cited by 26
“One explanation for this paradox is the proximity of the enzyme to the endoplasmic reticulum membrane (Lakshmi & Monder 1988, Walker et al. 2001, Hosfield et al. 2005, Zhang et al. 2005).”
BackgroundKraft, M., Knüpfer, U., Wenderoth, R., Kacholdt, A., Pietschmann, P., Hock, B. M., & Horn, U. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1121-7 · Cited by 22
“The primary structure of both human 11β-HSD isoenzymes contribute to the low-level expression observed in E. coli (Walker et al. 2001).”
BackgroundInfluentialYang, W.-L., Peng, L.-S., Zhong, X., Wei, J.-W., Jiang, X.-Y., Ye, L., Zou, L., Tu, H.-B., Wu, W.-Y., & Xu, A.-L. (2003) · Toxicon · doi:10.1016/s0041-0101(03)00047-3 · Cited by 21
Nobel, S., Dunås, F., & Abrahmsén, L. (2002) · Protein Expression and Purification · doi:10.1016/s1046-5928(02)00547-8 · Cited by 25
High-level production and optimization of monodispersity of 11β-hydroxysteroid dehydrogenase type 1
Elleby, B., Svensson, S., Wu, X., Stefansson, K., Nilsson, J., Hallén, D., Oppermann, U. C. T., & Abrahmsén, L. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.05.003 · Cited by 27
The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1
Zhou, H.-Y., Hu, G., Lian, Q., Morris, D. J., & Ge, R. (2011) · Toxicology · doi:10.1016/j.tox.2011.11.012 · Cited by 22
Cofactor-specific modulation of 11β-hydroxysteroid dehydrogenase 1 inhibitor potency
Sahni-Arya, B., Flynn, M. J., Bergeron, L., Salyan, M. E. K., Pedicord, D. L., Golla, R., Ma, Z., Wang, H., Seethala, R., Wu, S. C., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.07.005 · Cited by 18
König, L., Hartz, P., Bernhardt, R., & Hannemann, F. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.06.005 · Cited by 18
2 Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Su, X., Vicker, N., & Potter, B. V. L. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00002-1 · Cited by 18
Kim, K. W., Wang, Z., Busby, J., Tsuruda, T. S., Chen, M., Hale, C., Castro, V. M., Svensson, S., Nybo, R. E., Xiong, F., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.02.008 · Cited by 20
Tagawa, N., Kubota, S., Kobayashi, Y., & Kato, I. (2014) · Steroids · doi:10.1016/j.steroids.2014.11.003 · Cited by 18
“At present for human [30] and rabbit [31] 11b-HSD1, it has been suggested that glycosylation is not required for correct protein folding or enzyme activity.”
Lawson, A. J., Walker, E. A., White, S. A., Dafforn, T. R., Stewart, P. M., & Ride, J. P. (2009) · Protein Science · doi:10.1002/pro.150 · Cited by 13
“For this purpose, we chose to introduce mutations into an N-terminally truncated, His-tagged enzyme, produced in the bacterial expression system we had previously developed and validated.(17) C-terminal mutations introduced into the human enzyme were L266E, I275E, F278E, and Table II.”
BackgroundMethodInfluentialSelf-citationZhang, R., Xu, Y., Xiao, R., Wang, S., & Zhang, B. (2010) · Process Biochemistry · doi:10.1016/j.procbio.2010.11.016 · Cited by 12
Auchus, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00008-9 · Cited by 15
Purification and reconstitution of human membrane-bound DHRS7 (SDR34C1) from Sf9 cells
Skarka, A., Zemanová, L., Navrátilová, H., & Wsól, V. (2013) · Protein Expression and Purification · doi:10.1016/j.pep.2013.11.013 · Cited by 9
Assay optimization and kinetic profile of the human and the rabbit isoforms of 11β-HSD1
Castro, A., Zhu, J. X., Alton, G., Rejto, P. A., & Ermolieff, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.005 · Cited by 10
Park, S. Y., Bae, J. H., & Cho, Y. S. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.3008 · Cited by 9
“H6PDH catalyses glucose 6-phosphate to 6-phospho-gluconolactone (G6P=O) with generation of NADPH, which is utilized by 11β-HSD1 for the reduction of 11-dehydrocorticosterone to corticosterone.(2,3) On the other hand, 11β-HSD2 drives a unidirectional oxidative reaction, using NAD+ as a cofactor, for the conversion of c…”
BackgroundJu, R., Wu, W., Tang, Q., Wu, D., Xia, Y., Wu, J., & Wang, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140326 · Cited by 7
“Many researches proved that theHSD11B1 linked to various metabolic abnormalities and the importance has been testified in obesity and insulin resistance and other components of the metabolic syndrome [19, 21, 25, 26].”
BackgroundBlum, A., & Maser, E. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00224-7 · Cited by 7
Koike, T., Shiraki, R., Sasuga, D., Hosaka, M., Kawano, T., Fukudome, H., Kurosawa, K., Moritomo, A., Mimasu, S., Ishii, H., et al. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00211 · Cited by 8
Robinzon, B., & Prough, R. A. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.04.010 · Cited by 5
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00096-4 · Cited by 6
11β-Hydroxysteroid Dehydrogenases in the Regulation of Tissue Glucocorticoid Availability
Pereira, C., Monteiro, R., Constância, M., & João, M. (2012) · InTech eBooks · doi:10.5772/53645 · Cited by 3
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
Yu, V. L., Tudor, Y., Hale, C., Plant, M., Kim, K. W., Wang, M., Nguyen, Y., Miguel, T. S., Chen, M., Nybo, R. E., et al. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.047 · Cited by 1
11beta-hydroxysteroid dehydrogenase type 1 as a pharmacological target in metabolic disease
Hult, M. (2004) · Figshare
Zhang, L. (2010) · UWSpace (University of Waterloo)
BindingDB (2010) · UC San Diego · doi:10.7270/q2bp02w3
Metadata
- Authors
- Walker, E. A., Clark, A. M., Hewison, M., Ride, J. P., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 276
- Issue
- 24
- Pages
- 21343-21350
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2048885419
- Semantic Scholar
- af0b2b83171efa75ca41f624dbef34b4ab1bb44b
- Cited by
- 65
- References
- 38
- Citations by year
- 2021: 1 · 2019: 2 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 5
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7062 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, catalytic domain, recombinant protein expression, Escherichia coli expression, thioredoxin fusion, disulfide bonds, protein glycosylation, transmembrane domain, enzyme purification, dehydrogenase activity, reductase activity, cortisone, cortisol, cysteine mutations, protein dimerization
- MeSH terms
- Amino Acid Sequence, Chromatography, Thin Layer, Cloning, Molecular, Electrophoresis, Polyacrylamide Gel, Escherichia coli, Glycosylation, Humans, Hydroxysteroid Dehydrogenases, Molecular Sequence Data, Peptide Fragments, Recombinant Proteins, Blotting, Western, Restriction Mapping, Mutagenesis, Site-Directed, Amino Acid Substitution, Catalytic Domain, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.